These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32390704)

  • 1. Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation.
    Fallet E; Rayar M; Landrieux A; Camus C; Houssel-Debry P; Jezequel C; Legros L; Uguen T; Ropert-Bouchet M; Boudjema K; Guyader D; Bardou-Jacquet E
    World J Gastroenterol; 2020 Apr; 26(16):1938-1949. PubMed ID: 32390704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors of Mortality After Liver Transplantation in Uruguay.
    Olivari D; Mainardi V; Rando K; Rey G; Menendez J; Prieto J; Medina J; Valverde M; Castelli J; Grecco G; Leites A; Zunini G; Gozalez S; Harguindeguy M; Gerona S
    Transplant Proc; 2018 Mar; 50(2):499-502. PubMed ID: 29579835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
    Al-Freah MA; Kriese S; Foxton MR; Quaglia A; Bomford A; Heaton ND; O'Grady JG; Agarwal K; Wendon JA; Heneghan MA
    Transpl Int; 2013 Nov; 26(11):1070-9. PubMed ID: 24138201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival.
    Weismüller TJ; Kirchner GI; Scherer MN; Negm AA; Schnitzbauer AA; Lehner F; Klempnauer J; Schlitt HJ; Manns MP; Strassburg CP
    Hepatology; 2011 Dec; 54(6):2114-24. PubMed ID: 21898488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
    Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
    Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
    Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes.
    Chua AC; Knuiman MW; Trinder D; Divitini ML; Olynyk JK
    Am J Clin Nutr; 2016 Sep; 104(3):736-42. PubMed ID: 27488234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
    Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
    J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
    Fernández-Ruiz M; López-Medrano F; Andrés A; Morales JM; Lumbreras C; San-Juan R; Polanco N; González E; Aguado JM
    Transpl Infect Dis; 2013 Dec; 15(6):600-11. PubMed ID: 24011120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-related markers are associated with infection after liver transplantation.
    Chow JKL; Ganz T; Ruthazer R; Simpson MA; Pomfret EA; Gordon FD; Westerman ME; Snydman DR
    Liver Transpl; 2017 Dec; 23(12):1541-1552. PubMed ID: 28703464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Severe Deficits in Performance Status at Time of Liver Transplant is Associated With Significantly Higher Risk of Death Following Liver Transplantation.
    McCabe P; Gish RG; Cheung R; Wong RJ
    J Clin Gastroenterol; 2019 Oct; 53(9):e392-e399. PubMed ID: 30762610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
    Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.
    Sharma P; Parikh ND; Yu J; Barman P; Derstine BA; Sonnenday CJ; Wang SC; Su GL
    Liver Transpl; 2016 Aug; 22(8):1092-8. PubMed ID: 27064263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.